LON:DIL2

Damille Investments Ii Share Forecast, Price & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume939 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive DIL2 News and Ratings via Email

Sign-up to receive the latest news and ratings for Damille Investments Ii and its competitors with MarketBeat's FREE daily newsletter.


About Damille Investments Ii

Damille Investments II Limited is a Guernsey-based closed-ended investment company. The Company's principal activity is to realize capital growth from a portfolio of equities and to generate a capital return to shareholders. The Company's investment objective is to realize significant capital returns for its shareholders with low volatility, by investing in a concentrated portfolio of primarily equity securities. Its investments by sectors include natural resources, real estate, cash, corporates, holding companies, private equity and other listed funds. The Company is self-managed. It invests in warrants, which are valued using a warrant calculator using observable market inputs. It also invests in managed funds, which are not quoted in an active market and which may be subject to restrictions on redemptions.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.88 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Damille Investments Ii (LON:DIL2) Frequently Asked Questions

What stocks does MarketBeat like better than Damille Investments Ii?

Wall Street analysts have given Damille Investments Ii a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Damille Investments Ii wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

What is Damille Investments Ii's stock symbol?

Damille Investments Ii trades on the London Stock Exchange (LON) under the ticker symbol "DIL2."

How do I buy shares of Damille Investments Ii?

Shares of DIL2 and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.


This page was last updated on 8/5/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.